BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36920288)

  • 21. A Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma.
    Baranov E; McBride MJ; Bellizzi AM; Ligon AH; Fletcher CDM; Kadoch C; Hornick JL
    Am J Surg Pathol; 2020 Jul; 44(7):922-933. PubMed ID: 32141887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase transition and remodeling complex assembly are important for SS18-SSX oncogenic activity in synovial sarcomas.
    Cheng Y; Shen Z; Gao Y; Chen F; Xu H; Mo Q; Chu X; Peng CL; McKenzie TT; Palacios BE; Hu J; Zhou H; Long J
    Nat Commun; 2022 May; 13(1):2724. PubMed ID: 35585082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of novel SSX1 fusions in synovial sarcoma.
    Yoshida A; Arai Y; Satomi K; Kubo T; Ryo E; Matsushita Y; Hama N; Sudo K; Komiyama M; Yatabe Y; Shibata T; Ichikawa H; Ichimura K; Kawai A; Mori T
    Mod Pathol; 2022 Feb; 35(2):228-239. PubMed ID: 34504309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone deacetylase inhibitors reverse SS18-SSX-mediated polycomb silencing of the tumor suppressor early growth response 1 in synovial sarcoma.
    Lubieniecka JM; de Bruijn DR; Su L; van Dijk AH; Subramanian S; van de Rijn M; Poulin N; van Kessel AG; Nielsen TO
    Cancer Res; 2008 Jun; 68(11):4303-10. PubMed ID: 18519690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paracrine osteoprotegerin and β-catenin stabilization support synovial sarcomagenesis in periosteal cells.
    Barrott JJ; Illum BE; Jin H; Hedberg ML; Wang Y; Grossmann A; Haldar M; Capecchi MR; Jones KB
    J Clin Invest; 2018 Jan; 128(1):207-218. PubMed ID: 29202462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the Wnt pathway in synovial sarcoma models.
    Barham W; Frump AL; Sherrill TP; Garcia CB; Saito-Diaz K; VanSaun MN; Fingleton B; Gleaves L; Orton D; Capecchi MR; Blackwell TS; Lee E; Yull F; Eid JE
    Cancer Discov; 2013 Nov; 3(11):1286-301. PubMed ID: 23921231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma.
    Amary MF; Berisha F; Bernardi Fdel C; Herbert A; James M; Reis-Filho JS; Fisher C; Nicholson AG; Tirabosco R; Diss TC; Flanagan AM
    Mod Pathol; 2007 Apr; 20(4):482-96. PubMed ID: 17334349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy.
    Nielsen TO; Poulin NM; Ladanyi M
    Cancer Discov; 2015 Feb; 5(2):124-34. PubMed ID: 25614489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic ConFUSION: SS18-SSX Fusion Rewires BAF Complex to Activate Bivalent Genes in Synovial Sarcoma.
    Morgan MA; Shilatifard A
    Cancer Cell; 2018 Jun; 33(6):951-953. PubMed ID: 29894696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential roles of SS18-SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth.
    Törnkvist M; Natalishvili N; Xie Y; Girnita A; D'Arcy P; Brodin B; Axelson M; Girnita L
    Biochem Biophys Res Commun; 2008 Apr; 368(3):793-800. PubMed ID: 18267106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma.
    Mihály D; Nagy N; Papp G; Pápai Z; Sápi Z
    Diagn Pathol; 2018 Oct; 13(1):81. PubMed ID: 30326929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics.
    Su L; Sampaio AV; Jones KB; Pacheco M; Goytain A; Lin S; Poulin N; Yi L; Rossi FM; Kast J; Capecchi MR; Underhill TM; Nielsen TO
    Cancer Cell; 2012 Mar; 21(3):333-47. PubMed ID: 22439931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SS18-SSX Expression in a Contemporary Cohort of Primary Renal Synovial Sarcoma: A Multi-Institutional Experience of Fourteen Patients.
    Challa B; Mohanty SK; Jha S; Sampat NY; Sardana R; Lobo A; Sharma S; Arora S; Rath D; Munjal G; Pattnaik N; Jain D; Jain E; Dewan A; Dixit M; Malik V; Shinde S; Balzer BL; Parwani A
    Int J Surg Pathol; 2023 Oct; 31(7):1232-1243. PubMed ID: 36591871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlating SS18-SSX immunohistochemistry (IHC) with SS18 fluorescent in situ hybridization (FISH) in synovial sarcomas: a study of 36 cases.
    Tay TKY; Sukma NB; Lim TH; Kuick CH; Goh JY; Chang KTE
    Virchows Arch; 2021 Oct; 479(4):785-793. PubMed ID: 34091760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoreactivity of a Monoclonal Antibody to SS18-SSX Fusion Gene Product in Formalin-fixed Paraffin-embedded Synovial Sarcoma Tissue Section.
    Saigo C; Kito Y; Takeuchi T
    Appl Immunohistochem Mol Morphol; 2018 Mar; 26(3):206-211. PubMed ID: 27362474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The C terminus of the synovial sarcoma-associated SSX proteins interacts with the LIM homeobox protein LHX4.
    de Bruijn DR; van Dijk AH; Willemse MP; van Kessel AG
    Oncogene; 2008 Jan; 27(5):653-62. PubMed ID: 17667940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel FISH assay for SS18-SSX fusion type in synovial sarcoma.
    Surace C; Panagopoulos I; Pålsson E; Rocchi M; Mandahl N; Mertens F
    Lab Invest; 2004 Sep; 84(9):1185-92. PubMed ID: 15208645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deflection of vascular endothelial growth factor action by SS18-SSX and composite vascular endothelial growth factor- and chemokine (C-X-C motif) receptor 4-targeted therapy in synovial sarcoma.
    Wakamatsu T; Naka N; Sasagawa S; Tanaka T; Takenaka S; Araki N; Ueda T; Nishizawa Y; Yoshikawa H; Itoh K
    Cancer Sci; 2014 Sep; 105(9):1124-34. PubMed ID: 24975049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression profiling of low-grade endometrial stromal sarcoma indicates fusion protein-mediated activation of the Wnt signaling pathway.
    Przybyl J; Kidzinski L; Hastie T; Debiec-Rychter M; Nusse R; van de Rijn M
    Gynecol Oncol; 2018 May; 149(2):388-393. PubMed ID: 29544705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of SS18-SSX fusion-specific antibody and SSX C-terminal antibody in synovial sarcoma and its diagnostic value].
    Wang X; Cheng K; Wu N; Li R; Chen H; Ma HH; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):740-744. PubMed ID: 34405607
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.